Search results - ORA - Oxford University Research Archive

1

Journal article

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

Mease, PJ, Merola, JF, Tanaka, Y, et al.
2024-08-31

2

Journal article

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

Gossec, L, Coates, LC, Gladman, DD, et al.
2024-08-20

3

Journal article

Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1 year results from two phase 3 studies

Gossec, L, Orbai, AM, de Wit, M, et al.
2024

4

Journal article

Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial

Strand, V, Gossec, L, Coates, LC, et al.
2024-05-07

5

Journal article

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

Coates, LC, Gossec, L, Zimmermann, M, et al.
2024-03-26

6

Journal article

How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

Coyle, C, Watson, L, Whately-Smith, C, et al.
2024-01-08

7

Journal article

An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis

Watson, L, Coyle, C, Whately-Smith, C, et al.
2023-11-27

8

Journal article

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study

Leung, Y-Y, Eder, L, Orbai, A-M, et al.
2023-09-14

9

Journal article

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase 3, randomised, placebo controlled, active reference BE OPTIMAL study

Ritchlin, CT, Coates, LC, McInnes, IB, et al.
2023-05-30

10

Journal article

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group

Leung, Y-Y, Tillett, W, de Wit, M, et al.
2023-11-01

11

Journal article

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries

Sousa, M, Lubrano, E, Smolen, JS, et al.
2022-12-15

12

Journal article

Bimekizumab in patients with active psoriatic arthritis and prior inadequate response or intolerance to tumour necrosis factor inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

Merola, JF, Landewé, R, McInnes, IB, et al.
2022-12-06

13

Journal article

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

McInnes, IB, Asahina, A, Coates, LC, et al.
2023-01-06

14

Journal article

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences

Coates, L, Gossec, L
2022-09-29

15

Journal article

Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial

Baraliakos, X, Pournara, E, Gossec, L, et al.
2022-07-18

16

Journal article

Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force

Ovseiko, PV, Gossec, L, Andreoli, L, et al.
2022-08-08

17

Journal article

Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis

Coates, L, Ritchlin, CT, Gossec, L, et al.
2022-06-29

18

Journal article

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries

Lucasson, F, Kiltz, U, Kalyoncu, U, et al.
2022-05-06

19

Journal article

Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences?

Hassan, N, van Mens, L, Kiltz, U, et al.
2022-03-04

20

Journal article

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)

Coates, L, Gossec, L, Theander, E, et al.
2021-11-24

21

Conference item

Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free

Coates, LC, Ritchlin, CT, Gossec, L, et al.
2021-05-19

22

Conference item

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Baraliakos, X, Gossec, L, Pournara, E, et al.
2021-04-26

23

Journal article

The key comorbidities in patients with rheumatoid arthritis: a narrative review

Taylor, PC, Atzeni, F, Balsa, A, et al.
2021-02-01

24

Journal article

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

Baraliakos, X, Gossec, L, Pournara, E, et al.
2020-12-17

25

Conference item

EULAR task force on gender equity in academic rheumatology: preliminary survey findings

Ovseiko, PV, Gossec, L, Andreoli, L, et al.
2020-06-02

26

Journal article

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study

Coates, L, Nash, P, Kvien, TK, et al.
2020-05-15

27

Journal article

Égalité femmes-hommes dans la pratique clinique, la recherche et la formation : où en est la rhumatologie ?

Andreoli, L, Ovseiko, PV, Hassan, N, et al.
2019-11-15

28

Journal article

Comparing the patient reported physical function outcome measures in a real‐life international cohort of patients with psoriatic arthritis

Leung, YY, Orbai, AM, de Wit, M, et al.
2021-03-13

29

Journal article

Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients

Orbai, A-M, McInnes, IB, Coates, LC, et al.
2019-10-15

30

Journal article

Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with gender in 458 patients from 14 countries

Orbai, A, Perin, J, Gorlier, C, et al.
2019-10-14

31

Journal article

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

Orbai, A-M, Ogdie, A, Gossec, L, et al.
2019-10-18

32

Journal article

Gender equity in clinical practice, research and training: Where do we stand in rheumatology?

Andreoli, L, Ovseiko, P, Hassan, N, et al.
2019-06-17

33

Journal article

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis

Coates, L, Gossec, L, Ramiro, S, et al.
2017-01-11

34

Journal article

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

Coates, L, Gladman, D, Nash, P, et al.
2018-12-07

35

Journal article

PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials

Orbai, A, Holland, R, Leung, Y, et al.
2018-12-15

36

Journal article

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries

Gorlier, C, Orbai, A, Puyraimond-Zemmour, D, et al.
2018-11-15

37

Journal article

Minimal disease activity among active psoriatic arthritis patients treated with secukinumab: 2‐year results from a multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

Coates, L, Mease, P, Gossec, L, et al.
2018-02-06

38

Journal article

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

Smolen, JS, Schöls, M, Braun, J, et al.
2017-07-06

39

Journal article

Improving the management of psoriatic arthritis and axial spondyloarthritis: Roundtable discussions with healthcare professionals and patients

Garrido-Cumbrera, M, Hillmann, O, Mahapatra, R, et al.
2017-06-09

40

Journal article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Smolen, J, Landewé, R, Bijlsma, J, et al.
2017-03-06

41

Journal article

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program.

Grøn, K, Ornbjerg, L, Hetland, M, et al.
2014-01-01

42

Journal article

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Khan, N, Spencer, H, Abda, E, et al.
2012-12-01

43

Journal article

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.

Sokka, T, Kautiainen, H, Toloza, S, et al.
2007-11-01

44

Journal article

Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity.

Khan, N, Yazici, Y, Calvo-Alen, J, et al.
2009-11-01

EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH